Related Experiment Videos
Early experience with cyclosporine: a historic perspective
12nd Department of Propedeutic Surgery, Athens University, Medical School, Laiko General Hospital, Athens, Greece. akostak@med.uoa.gr
Transplantation Proceedings
|March 26, 2004
Summary
Cyclosporine, a potent immunosuppressive drug, significantly prolonged heart allograft survival in rat transplantation models. These findings demonstrated its efficacy in preventing organ rejection, with potential applications in humans.
Area of Science:
- Immunology
- Transplantation Biology
- Pharmacology
Background:
- Organ transplantation faces challenges due to immune rejection.
- Antilymphocyte agents are crucial for preventing graft rejection.
Purpose of the Study:
- To evaluate the efficacy of cyclosporine as an antilymphocyte peptide.
- To assess its impact on heterotopic heart allograft survival in rats.
Main Methods:
- Heterotopic heart transplantation was performed between two different rat strains.
- Cyclosporine was administered to assess its immunosuppressive effects.
Main Results:
- Cyclosporine treatment led to a statistically significant prolongation of rat heart allograft survival (P<.001).
- A marked reduction in allograft rejection episodes was observed in treated rats compared to controls.
Conclusions:
- Cyclosporine is a highly potent immunosuppressive agent effective in preventing allograft rejection.
- These findings support the potential clinical application of cyclosporine in human transplantation.